Envoy Medical
COCH
80 hedge funds and large institutions have $319M invested in Envoy Medical in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 3 closing their positions.
467% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 3
36% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 11
36% more capital invested
Capital invested by funds: $235M → $319M (+$83.9M)
20.03% more ownership
Funds ownership: 56.99% → 77.02% (+20%)
18% more funds holding
Funds holding: 68 → 80 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$26.1M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$24.2M |
| 3 |
D.E. Shaw & Co
New York
|
+$9.9M |
| 4 |
Millennium Management
New York
|
+$5.93M |
| 5 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$4.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.46M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$927K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$798K |
| 4 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$679K |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$244K |
COCH Hedge Fund Activity: Q4 2021 in Review
80 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2021, worth a combined $319M — up 36% from $235M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new COCH positions and 3 closed out — a net gain of 14 holders — while 15 added to existing stakes and 11 trimmed.
The largest buyer was Aristeia Capital, opening a new position worth an estimated $26.1M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $1.46M sold.
- 80 institutional investors held Envoy Medical (COCH) as of Q4 2021, up from 68 in Q3 2021.
- Funds reported $319M of Envoy Medical stock for Q4 2021, up 36% quarter-over-quarter.
- 17 funds opened new Envoy Medical positions in Q4 2021 and 3 closed out, a net change of +14 holders.
- The largest Envoy Medical buyer in Q4 2021 was Aristeia Capital, an estimated $26.1M added.
- The largest Envoy Medical seller in Q4 2021 was Monashee Investment Management, an estimated $1.46M sold.
Based on aggregated 13F filings for Q4 2021.